Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Gold/Mining/Energy : PYNG Technologies -- Ignore unavailable to you. Want to Upgrade?

To: LOR who wrote (7977)	11/2/2005 11:43:57 AM
From: Jack Rayfield	Read Replies (1) \| Respond to of 8117

LOR I have researched the IO infusion players and as far as I can tell Pyng is the only serious sternal option (jamashidi needle is not a serious competitor in my opinion) . All of the other IO infusion devices use the Tibia as the primary insertion location with the ankle, wrist and shoulder as alternate sites. I do not think there is any chance that the FDA would approve any other device for sternal insertion unless it has depth control which all of the other devices lack as the depth is either manually determined or roughly set (BIG red or blue). In the sternal site depth control is a critical factor with very little room for error. Best Regards Jack